IPHA

Innate Pharma SA is a pioneering biotechnology firm headquartered in Marseille, France, specializing in the development of groundbreaking therapeutic antibodies for oncological applications. The company boasts a diverse pipeline of proprietary immune-oncology candidates designed to improve treatment outcomes for cancer patients worldwide. With its strong focus on monoclonal antibody and immune-mediated therapies, Innate Pharma is well-positioned to capitalize on the increasing global demand for innovative cancer therapies, which enhances its growth prospects and market competitiveness.